Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRO
Marathon Oil Corporation
MRO
|
+$180M |
| 2 |
BHI
Baker Hughes
BHI
|
+$173M |
| 3 |
Dominion Energy
D
|
+$161M |
| 4 |
Kinder Morgan
KMI
|
+$155M |
| 5 |
Marathon Petroleum
MPC
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
+$177M |
| 2 |
SLB Ltd
SLB
|
+$121M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$119M |
| 4 |
PepsiCo
PEP
|
+$110M |
| 5 |
Mastercard
MA
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 15.14% |
| 2 | Healthcare | 12.64% |
| 3 | Financials | 8.59% |
| 4 | Utilities | 7.75% |
| 5 | Technology | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $1.68B | 4.25% |
8,528,400
+2,972,800
| +54% | +$588M |
|
|
BHI
2
DELISTED
Baker Hughes
BHI
| $400M | 1.01% |
6,155,711
+2,486,594
| +68% | +$173M |
|
|
APC
3
DELISTED
Anadarko Petroleum
APC
| $336M | 0.85% |
3,310,058
+881,359
| +36% | +$95.1M |
|
4
Teva Pharmaceuticals
TEVA
$43.5B
| $280M | 0.71% |
5,206,942
+1,182,407
| +29% | +$62.6M |
|
5
NextEra Energy
NEE
$174B
| $262M | 0.66% |
11,151,152
+1,605,452
| +17% | +$38.8M |
|
6
Sempra
SRE
$54.2B
| $253M | 0.64% |
4,803,184
+1,095,124
| +30% | +$56.4M |
|
7
AbbVie
ABBV
$468B
| $248M | 0.63% |
4,291,969
+1,500,525
| +54% | +$83.3M |
|
8
American Electric Power
AEP
$65.8B
| $243M | 0.62% |
4,658,458
-713,792
| -13% | -$37.7M |
|
9
NRG Energy
NRG
$23.8B
| $238M | 0.6% |
7,808,152
+2,699,147
| +53% | +$84.3M |
|
10
Exelon
EXC
$45.1B
| $236M | 0.6% |
9,690,597
-865,967
| -8% | -$20.3M |
|
|
PPL
11
PPL Corp
PPL
$25.9B
| $224M | 0.57% |
7,308,319
-2,924,442
| -29% | -$91.5M |
|
|
AGN
12
DELISTED
Allergan plc
AGN
| $209M | 0.53% |
867,868
+588,534
| +211% | +$132M |
|
|
WPX
13
DELISTED
WPX Energy, Inc.
WPX
| $205M | 0.52% |
8,509,993
+5,388,273
| +173% | +$128M |
|
|
14
Dominion Energy
D
$58.6B
| $191M | 0.48% |
2,758,239
+2,336,536
| +554% | +$161M |
|
|
15
Marathon Petroleum
MPC
$101B
| $184M | 0.47% |
4,347,522
+3,639,228
| +514% | +$154M |
|
|
MRO
16
DELISTED
Marathon Oil Corporation
MRO
| $182M | 0.46% |
4,829,645
+4,535,835
| +1,544% | +$180M |
|
17
Devon Energy
DVN
$54B
| $175M | 0.44% |
2,572,378
-969,960
| -27% | -$72.1M |
|
|
EGN
18
DELISTED
Energen
EGN
| $172M | 0.44% |
2,386,059
+1,036,783
| +77% | +$82.9M |
|
19
CenterPoint Energy
CNP
$25.5B
| $167M | 0.42% |
6,813,413
-847,664
| -11% | -$20.9M |
|
|
20
Kinder Morgan
KMI
$69B
| $157M | 0.4% |
4,093,664
+4,071,959
| +18,760% | +$155M |
|
|
RDC
21
DELISTED
Rowan Companies Plc
RDC
| $154M | 0.39% |
6,073,079
+3,060,952
| +102% | +$90.3M |
|
22
Biogen
BIIB
$32B
| $147M | 0.37% |
445,663
+352,491
| +378% | +$116M |
|
|
GPOR
23
DELISTED
Gulfport Energy Corp.
GPOR
| $145M | 0.37% |
2,724,580
+1,156,736
| +74% | +$66.4M |
|
|
AGN
24
DELISTED
Allergan Inc
AGN
| $137M | 0.35% |
770,977
+248,442
| +48% | +$41.3M |
|
|
WLL
25
DELISTED
Whiting Petroleum Corporation
WLL
| $136M | 0.34% |
5,853
+763
| +15% | +$19.5M |
|
Similar funds
Israel Englander's Q3 2014 Portfolio in Review
As of Q3 2014, Israel Englander held 4,400 positions worth $39.5B, up 9.5% from $36.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander deployed $4.94B of net new capital in Q3 2014, opening 1,066 new positions and adding to 1,336 existing holdings. Its largest new stake was St Jude Medical: 1,407,737 shares worth $84.6M.
By sector, the portfolio is most concentrated in Energy at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was SLB Ltd, an estimated $121M trimmed.
- Israel Englander's largest Q3 2014 buy was St Jude Medical: 1,407,737 shares worth $84.6M.
- Israel Englander added most to Marathon Oil Corporation in Q3 2014, an estimated $180M increase.
- Israel Englander's biggest Q3 2014 reduction was SLB Ltd, cutting an estimated $121M.
- Israel Englander fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 11% of its $39.5B portfolio in Q3 2014.
- Israel Englander opened 1,066 new positions and closed 749 in Q3 2014.
- Israel Englander's portfolio value rose 9.5% quarter-over-quarter to $39.5B.
Based on Millennium Management's 13F filing for Q3 2014, filed 14 Nov 2014.